Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2020.03.19.999466

Population structure in Arctic marine forests is shaped by diverse recolonisation pathways and far northern glacial refugia

Bringloe, T. T.·Verbruggen, H.·Saunders, G. W.
View original source ↗Export metadata ↓

Abstract

The Arctic is experiencing a rapid shift towards warmer regimes, calling for a need to understand levels of biodiversity and ecosystem responses to climate cycles. This study examines marine refugial locations during the Last Glacial Maximum in order to link recolonization pathways to patterns of genetic diversity in Arctic marine forests. We present genetic data for 109 species of seaweed to infer community-level patterns, and hindcast species distributions during the Last Glacial Maximum to further pinpoint likely refugial locations. Sequence data revealed contiguous populations extending from the Bering Sea to the Northwest Atlantic, with high levels of genetic diversity in the East Canadian Arctic. One fifth of the species sampled appeared restricted to Arctic waters. Hindcasted species distributions highlighted refugia in the Bering Sea, Northwest Atlantic, South Greenland, and Europe. We hypothesize that Arctic coastal systems were recolonized from many geographically disparate refugia leading to enriched diversity levels in the East Canadian Arctic, with important contributions stemming from northerly refugia likely centered along Southern Greenland. Moreover, we hypothesize these northerly refugia likely played a key role in promoting polar endemic diversity, as reflected by abundant unique population haplotypes and endemic species in the East Arctic. Significance StatementOur work challenges the existing paradigm that marine Arctic ecosystems are depauperate extensions of southerly (temperate) communities established in the wake of recent glaciation, fundamentally changing how these systems should be viewed and interpreted. We forward novel hypotheses regarding the recent history of Arctic marine systems, particularly with regards to endemism being an integral feature of Arctic biomes, and present a firm framework for future evolutionary research in this system typically viewed as "ecologically immature."

Source connections

Explore related subjects

geneticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bringloe, T. T., Verbruggen, H., Saunders, G. W.. 2020-03-20. Population structure in Arctic marine forests is shaped by diverse recolonisation pathways and far northern glacial refugia. https://doi.org/10.1101/2020.03.19.999466

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗
bioRxiv2026

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗
bioRxiv2026

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗